Rates of preeclampsia are rising rapidly, yet surprisingly there are few national estimates of the health and economic impact of preeclampsia on mothers and their infants. A new study provides sobering data on this topic by examining the short-term costs associated with the condition. Significantly increasing the chance of adverse health outcomes, preeclampsia accounts for over $2.18 billion of health care expenditure in the first 12 months after birth.